NEU 2.37% $19.39 neuren pharmaceuticals limited

Neuren Media and Analyst Coverage, page-784

  1. 1,105 Posts.
    lightbulb Created with Sketch. 108
    If shares in a company couldn’t be bought or sold, there would be no liquidity and little chance for a start up to raise capital. Investors generally wouldn’t invest if there were no way to sell and realise profits. So I believe shareholders so have a critical role in publicly listed companies, at the very least they keep the system fluid.
    Owning Neuren shares does make some degree of impact and I don’t see a problem with being proud of investing in a company that improves people’s lives.
    But, we’re all in this to make money in the end and I’m under no illusion about my investment having a direct link with outcomes.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.39
Change
-0.470(2.37%)
Mkt cap ! $2.478B
Open High Low Value Volume
$19.70 $19.77 $19.28 $10.38M 534.0K

Buyers (Bids)

No. Vol. Price($)
3 2680 $19.35
 

Sellers (Offers)

Price($) Vol. No.
$19.41 362 1
View Market Depth
Last trade - 16.10pm 30/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.